The 20 Best Primitive Neuroectodermal Tumor (PNET) Doctors near New Hyde Park, NY

Dr. Goenka is board-certified in radiation oncology and physics and has extensive experience with proton radiotherapy, intensity modulated radiation therapy, stereotactic body radiation therapy and brachytherapy applications.He received his medical degree at Johns Hopkins University and completed his post graduate training at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of cancers of all subsites, including brain, head and neck, lung, breast, esophageal, colorectal/anal, prostate, and gynecological malignancies.Dr. Goenka is the recipient of several leadership awards, has published numerous articles and abstracts in national and international journals and has participated as a guest speaker internationally. He holds memberships at the American Medical Association, American Societyfor Therapeutic Radiology and Oncology, and American Association of Physicians of Indian Origin among others and is actively involved in Community Outreach programs. Dr. Goenka is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Oligodendroglioma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Gamma Knife Radiosurgery, and Gastrostomy.

Samuel Singer is a Neurologist in Lake Success, New York. Dr. Singer is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Bone Marrow Aspiration, and Tissue Biopsy.

"Michael Schulder, MD, is the vice chair of neurosurgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also the director of the Brain Tumor Center at the Institute for Neurology and Neurosurgery-which treats more than 600 patients annually-and co-director of the Center for Stereotactic Radiosurgery, where his team offers the latest treatment technologies. His research focuses on improving methods of image guidance for brain tumor surgery, and on new techniques for radiosurgery.""I've always been fascinated by the workings of the brain and how it gives rise to our thoughts, memories and personalities in ways that aren't fully understood,"" Dr. Schulder says. He attended medical school at Columbia University College of Physicians and Surgeons, and completed his residency in neurological surgery at the Albert Einstein College of Medicine. Dr. Schulder also trained in stereotactic neuro-oncology at the University of Florida and the Brigham and Women's Hospital.Dr. Schulder works with neuro-oncologists, radiation oncologists and other neurosurgeons to create evidence-based treatment plans. ""We offer close multidisciplinary collaboration to help avoid delay in seeing patients,"" he says. The team strives to offer minimally invasive treatments as often as possible.With a keen interest in neurosurgical image guidance-the use of real-time images of the brain to make procedures safer and more precise-Dr. Schulder is studying the next generation of intraoperative MRI. He runs a brain tumor clinical trials program, giving his patients ready access to innovative approaches to care. While performing complex neurosurgery is one of the most satisfying parts of Dr. Schulder's job, ""empathizing with patients and their families throughout treatment is equally fulfilling,"" he says.In addition to treating brain tumors, Dr. Schulder performs functional neurosurgery to manage pain conditions like trigeminal neuralgia, and movement disorders including essential tremor and Parkinson's disease. He is the program director of neurosurgical residency training at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Schulder is active in organized neurosurgery, where among other offices he is past president of the World Society for Stereotactic and Functional Neurosurgery, director-at-large of the American Association of Neurological Surgeons, and historian of the American Academy Neurological Surgery.". Dr. Schulder is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Gamma Knife Radiosurgery, and Awake Craniotomy.

Deborah Gruber is a Neurologist in Lake Success, New York. Dr. Gruber is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioblastoma, Glioma, Astrocytoma, and Gliomatosis Cerebri.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Teratocarcinosarcoma, and Olfactory Neuroblastoma.

Sang Sim is an Internal Medicine specialist and a Radiation Oncologist in New Hyde Park, New York. Dr. Sim is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Endometrial Cancer.

Richard Blanck is a Neurologist in New Hyde Park, New York. Dr. Blanck is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Memory Loss, and Primary Orthostatic Tremor.

Dwight Rosenstein is a Neurologist in New Hyde Park, New York. Dr. Rosenstein is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Migraine, Hemangioblastoma, Alternating Hemiplegia of Childhood, and Memory Loss.

Denis Ostrovskiy is a Neurologist in New Hyde Park, New York. Dr. Ostrovskiy is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Generalized Tonic-Clonic Seizure, Myasthenia Gravis, Transverse Myelitis, and Seizures.

Miriam A. Knoll, MD, joined Northwell Health in 2024 as a radiation oncologist. She is also a clinical assistant professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.After attending NYU Grossman School of Medicine, she completed a residency at the Icahn School of Medicine at Mount Sinai, before working at the John Theurer Cancer Center at Hackensack University Medical Center and Montefiore Nyack Hospital. She chose cancer care as a specialty in large part because she saw how collaborative that process needs to be for strong patient outcomes.I love working with a radiation oncology team, because that's truly what each patient needs, she says. Each of us contributes expertise and a different perspective, and that adds up to well-rounded care for each patient.At Northwell, Dr. Knoll's main focus is providing palliative radiation treatment. She communicates to patients how effective treatment can be for treating pain, and with far fewer side effects than many might expect. This type of therapy can really make a difference in helping people feel better, no matter where they are in their cancer journey.In addition to direct care, Dr. Knoll has worked to advance the field and to broaden patient knowledge and access by co-founding and serving at CEO of the Jewish Orthodox Women's Medical Association (JOWMA), as well as publishing articles in both academic journals and consumer publications such as JAMA Oncology, IJROBP, Advances in Radiation Oncology, Huffington Post and Forbes. She is an international speaker and writer focusing on medical care, the physician workforce, women in medicine, and social media in medicine. Dr. Knoll serves on national cancer committees at American Society of Clinical Oncology, American Society for Radiation Oncology, NRG Oncology, and the RTOG Foundation. She serves as a section editor for the journal Advances in Radiation Oncology.Over the course of her career, Dr. Knoll has learned from patients how valuable it is for those going through cancer to have a robust support system around them. That means family and friends and other patients, as well as a cancer care medical team.Ultimately, there are aspects of cancer that we can't control, although we step in and do as much as we can, she says. What we can control is offering as much support as possible so patients can draw on their own resilience for treatment. I see my role as being there for each patient on a personal level, while helping advance research and oncology care in a broader way. Dr. Knoll is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Primitive Neuroectodermal Tumor (PNET).

Cary Buckner is a Neurologist in New Hyde Park, New York. Dr. Buckner is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Memory Loss, Seizures, Guillain-Barre Syndrome, and Chronic Polyradiculoneuritis.

Rajiv Sharma is a Radiation Oncologist in Lake Success, New York. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Anal Cancer, Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy.

Nouneh Gostanian is an Oncologist in Lake Success, New York. Dr. Gostanian is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Ruby Sharma, MD, is an attending at the Monter Cancer Center where her clinical practice is solely dedicated to the treatment of patients with breast cancer. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board Certified in Internal Medicine, Medical Oncology, Hematology and Palliative Medicine, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Her research is focused on the prevention of disease, prevention of recurrence after surgery, and treatment of recurrences. She has a special interest in triple negative breast cancer and breast cancer diagnosed during pregnancy. Dr. Sharma is a member of the New York Metropolitan Breast Cancer Group, the American Society of Clinical Oncology, the American College of Physicians, American Society of Hematology and American Academy of Hospice and Palliative Medicine. She meets weekly with the interdisciplinary Breast Cancer Tumor Board, where challenging cases are reviewed. In addition to patient care, she is actively involved in the education of medical students, residents and fellows. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

Dr. Carleton, MD, is Associate Chief of the R.J. Zuckerberg Cancer Center at the Northwell Health Cancer Institute. Dr. Carleton, an expert in the treatment of breast cancer, joined the staff at North Shore University Hospital in 2002. A Massachusetts native, Dr. Carleton graduated from the University of Massachusetts Medical School and completed both her residency in Internal Medicine and fellowship in Hematology/Oncology at Tufts Medical Center in Boston. She then conducted two years of hematology research at the Beth Israel Deaconess Medical Center in Boston. Since joining the Northwell Health System she has focused her career primarily on breast cancer, including breast cancer prevention and the management of early stage and advanced breast cancer. She is actively involved in multidisciplinary disease oriented care models for these diseases. In addition to patient care she is actively involved in the education of medical students, residents and fellows, and participates in clinical research on breast cancer. She is an Assistant Professor of Medicine at the Hofstra Northwell School of Medicine. Dr. Carleton is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Beatrice Bloom is a Radiation Oncologist in Lake Success, New York. Dr. Bloom is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Endometrial Cancer, Adult Soft Tissue Sarcoma, Endometrial Stromal Sarcoma, and Cervical Cancer.